Age-related cognitive deficits, impaired long-term potentiation and reduction in synaptic marker density in mice lacking the β-amyloid precursor protein-Reference-Cited by-同舟云学术

Age-related cognitive deficits, impaired long-term potentiation and reduction in synaptic marker density in mice lacking the β-amyloid precursor protein

Published:1999-02 Issue:1 Volume:90 Page:1-13
ISSN:0306-4522
Container-title:Neuroscience
language:en
Short-container-title:Neuroscience

Author:

Dawson G.R,Seabrook G.R,Zheng H,Smith D.W,Graham S,O'Dowd G,Bowery B.J,Boyce S,Trumbauer M.E,Chen H.Y,Van der Ploeg L.H.T,Sirinathsinghji D.J.S

Publisher

Elsevier BV

Subject

General Neuroscience

Reference51 articles.

1. ApoE-4 and age of onset of Alzheimer's disease;Blacker;Neurology,1997

2. Reduction of neurological damage by a peptide segment of the amyloid β/A4 protein precursor in a rabbit spinal cord ischaemia model;Bowes;Expl Neurol.,1994

3. Expression of the amyloid protein precursor of Alzheimer's disease in the developing rat olfactory system;Clarris;Devl Brain Res.,1995

4. Behavioral phenotypes of inbred mouse strains: implications and recommendations for molecular studies;Crawley;Psychopharmacology,1997

5. Increased amyloid-β42(3) in the brains of mice expressing mutant presenilin 1;Duff;Nature,1996

Cited by 291 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Kismet/CHD7/CHD8 and Amyloid Precursor Protein-like Regulate Synaptic Levels of Rab11 at the Drosophila Neuromuscular Junction;International Journal of Molecular Sciences;2024-08-01

2. A multicenter, randomized, double-blind, placebo-controlled ascending dose study to evaluate the safety, tolerability, pharmacokinetics (PK) and pharmacodynamic (PD) effects of Posiphen in subjects with early Alzheimer’s Disease;Alzheimer's Research & Therapy;2024-07-05

3. Amyloid precursor protein combinatorial phosphorylation code regulates AMPA receptor removal during distinct forms of synaptic plasticity;Biochemical and Biophysical Research Communications;2024-05

4. A multicenter, randomized, double-blind, placebo-controlled ascending dose study to evaluate the safety, tolerability, pharmacokinetics (PK) and pharmacodynamic (PD) effects of Posiphen in subjects with Early Alzheimer’s Disease;2024-03-22

5. Extracellular disposal of nuclear waste by APP: a protective mechanism impaired in Alzheimer’s disease;2024-02-12